En Es
Categories

Industry News


Siemens Healthineers' Acquires Corindus to Enhance Robotic-Assisted Interventions

By Medimaging International staff writers
13 Aug 2019

Image: The CorPath GRX system (Photo courtesy of Corindus).Siemens Healthineers AG (Erlangen, Germany) has entered into a merger agreement with Corindus Vascular Robotics, Inc. (Boston, MA. USA) to acquire the company, which offers a robotic treatment platform for the major vascular therapeutic markets, including coronary, peripheral vascular and neurovascular interventions.

Corindus develops, produces and sells robotic systems for minimally invasive procedures. These systems help doctors to precisely control guide catheters, guide wires, balloon or stent implants via integrated imaging. The physician does not have to stand at the angiography table as usual but can control the procedure with a separate controlling module and is therefore, less exposed to radiation.

Siemens Healthineers’ acquisition of Corindus meets its objective of simplifying today's challenges in everyday hospital life. Robotic assisted minimally invasive procedures have the potential to reduce treatment times, increase precision during treatment, raise standardization levels in clinical procedures and ultimately improve clinical outcomes, which is the strategic focus of Siemens Healthineers’ Advanced Therapies business segment.

The CorPath systems developed by Corindus will be used along with angiography systems sold by Siemens Healthineers that make minimally invasive treatment possible by using high-quality imaging before and during medical interventions. The company's role in image-based minimally invasive procedures is now complemented by robotic-assisted precision medicine. This expansion strengthens Siemens Healthineers’ therapy position and underlines its role as one of the leading providers of solutions along the entire treatment path. The acquisition of Corindus marks a strategically significant extension of Siemens Healthineers’ therapy business.

The future integration of Siemens Healthineers’ digitization and artificial intelligence solutions with Corindus' robotic systems offers further promising possibilities. The aim is to further increase procedure optimization in order to enable the greatest possible degree of efficiency and clinical reproducibility. Additionally, Corindus is driving forward the approval procedure for remote robotic treatment in vascular interventions. Due to the limited availability of specialists for minimally invasive procedures in many regions and the limited number of corresponding clinical facilities, remote treatment could significantly improve patients' access to treatment in the future.

“Together with Corindus, Siemens Healthineers is well-positioned to be one of the leading players in the field of robotic vascular interventions and to perform minimally invasive procedures more accurately, more quickly and more effectively. With this acquisition, we are opening up a new field for our image-guided therapies business. Together with our strong portfolio in imaging, digitalization and artificial intelligence, we are creating significant synergies to advance therapy outcomes,” said Bernd Montag, CEO of Siemens Healthineers AG.

“The interplay of exact imaging and robotic-assisted interventions will enhance both the eyes and hands of the physician, metaphorically speaking. With the addition of Corindus to our strong therapies portfolio we sharpen our procedural focus and will grow by expanding precision medicine and improving clinical outcomes. In the future, our digital and artificial intelligence-based tools will help to integrate the aspects of image-guidance and therapy even further,” said Michel Therin, President Advanced Therapies at Siemens Healthineers.

“The collaboration with Siemens Healthineers is a unique opportunity to take our business to the next level and continue our success story. Together we plan to develop next-generation solutions that further improve patient care,” said Mark Toland, President and CEO at Corindus.



E-mail Print
FaceBook Twitter Google+ Linked in

Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for the medical industry
Silver member
More info

More articles about Siemens Healthineers

15 Oct 2019
Siemens Healthineers’ AI-Based Chest CT Software Receives US FDA Clearance
The US Food and Drug Administration (FDA) has cleared three modules of AI-Rad Companion Chest CT, an intelligent software assistant from Siemens Healthineers that brings artificial intelligence (AI) to computed tomography (CT).
Read More
05 Aug 2019
Siemens Healthineers Receives Recognition AI Applications in Radiology
Based on its recent analysis of the global precision imaging market, Frost & Sullivan, a growth strategy consulting and research firm, has recognized Siemens Healthineers with the 2019 Global Visionary Innovation Leadership Award for leading the effort to establish imaging as an active contributor to precision medicine.
Read More
07 Feb 2019
Global MRI Systems Market to Grow by USD 1.5 Billion in 2019-2023
The global MRI systems market size is projected to grow at a CAGR of more than 5%, or by almost USD 1.58 billion, during the forecast period 2019-2023, driven primarily by technological advances.
Read More
12 Nov 2018
Siemens Healthineers and Primary Health Care Enter Contract for In Vitro Diagnostics
Siemens Healthineers has entered into a strategic partnership with Australian integrated healthcare provider Primary Health Care to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers, marking the largest contract ever for in vitro diagnostics testing in the country.
Read More
06 Jun 2018
Siemens Healthineers and ScreenPoint Medical to Develop AI-Based Apps
Siemens Healthineers and ScreenPoint Medical have entered into a partnership to develop artificial intelligence (AI)-based applications for breast imaging. As part of the arrangement, Siemens Healthineers will also acquire a strategic minority stake in ScreenPoint Medical.
Read More
26 Apr 2018
Siemens Healthineers Launches Thermocycler with AI-Powered Software
Siemens Healthineers launched a new molecular thermocycler, the Fast Track cycler (FTC), and the complementary new FastFinder software at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018). The compact FTC allows laboratories of all sizes to implement molecular testing with simplicity and speed, while the FastFinder software improves workflow using Artificial Intelligence (AI)-powered automation.
Read More
27 Feb 2018
Siemens Healthineers AG IPO Planned for First Half of 2018
Global technology powerhouse Siemens AG and its separately managed healthcare business, Siemens Healthineers have announce that the planned IPO of Siemens Healthineers AG is expected to be completed in the first half of calendar year 2018, subject to capital market conditions.
Read More
18 Jan 2018
Siemens Healthineers Strategy 2025 to Focus on AI
Siemens Healthineers has laid out its strategy to bolster its market leadership by 2025 and beyond, aimed at accelerating profitable growth and delivering return. The company has stated that it is well prepared to take advantage of the paradigm shift and structural growth opportunities in healthcare.
Read More

Additional news

19 Feb 2020
New Artificial Intelligence Algorithm Boosts Quality of Brain Magnetic Resonance Imaging
 Researchers from the ICAI Group -Computational Intelligence and Image Analysis- of the University of Malaga {(UMA) Málaga, Spain) have designed a method that is capable of improving brain images obtained through magnetic resonance imaging using artificial intelligence (AI). The new model manages to increase image quality from low resolution to high resolution without distorting the patients' brain structures, using a deep learning artificial neural network - a model based on the functioning of the human brain - that "learns" this process.
Read More
17 Feb 2020
New System Combines Advanced Optical Imaging with AI Algorithm to Accurately Identify Brain Tumors
 Researchers from the NYU Grossman School of Medicine (New York, NY, USA) and the University of Michigan (Ann Arbor, MI, USA) have developed a novel method of combining advanced optical imaging with an artificial intelligence (AI) algorithm to produce accurate, real-time intraoperative diagnosis of brain tumors. The imaging technique, stimulated Raman histology (SRH), reveals tumor infiltration in human tissue by collecting scattered laser light, illuminating essential features not typically seen in standard histologic images. The microscopic images are then processed and analyzed with AI, allowing surgeons to see a predicted brain tumor diagnosis in less than three minutes. Using the same technology, after the resection, the surgeons can accurately detect and remove otherwise undetectable tumor.
Read More
10 Feb 2020
Global Medical Robotics Market to Reach USD 13.90 Billion by 2026
 The global medical robotics market is projected to grow at a double-digit CAGR from 2019 to 2026 to reach USD 13.90 billion by 2026, driven by the increasing demand for minimally invasive surgery, rising prevalence of gynecology, urology and orthopedic disorders, increasing aging population, technological innovations, growing adoption of medical robots among the population and increasing clinical trials.
Read More
04 Feb 2020
Patient Handling Equipment Market to Reach USD 12.6 Billion by 2024
 The global patient handling equipment market is projected to grow at a CAGR of 7.2% from USD 8.9 billion in 2019 to USD 12.6 billion by 2024, driven mainly by the rising geriatric population, high risk of injuries to caregivers during manual handling of patients, and regulations for ensuring the safety of healthcare personnel during manual lifting processes. However, continued difficulties in handling bariatric patients are expected to limit the market growth to some extent.
Read More
30 Jan 2020
Study Finds Most Healthcare Institutions Plan to Use AI and Develop Own AI Algorithm
 A new study of healthcare professionals has revealed that Artificial Intelligence (AI) is widely expected to drive important benefits across the health system, from increasing efficiency to improving patient outcomes, but may also be the key to making healthcare more human. AI’s benefits range from increasing the amount of time clinicians can spend with patients and on cross-care team collaboration to enhancing the ability to deliver preventative care.
Read More
30 Jan 2020
Quest Diagnostics Acquires Blueprint Genetics
 Quest Diagnostics (Secaucus, NJ, USA), a provider of diagnostic information services, has acquired Blueprint Genetics (Helsinki, Finland), a specialty genetic testing company with expertise in gene variant interpretation based on next generation sequencing (NGS) and proprietary bioinformatics. Together, Quest and Blueprint Genetics will broaden access to actionable insights in genetic and rare diseases, improving patient care and pharmaceutical drug research and development.
Read More
27 Jan 2020
JNJ Acquires Remaining Stake in Verb Surgical
 Johnson & Johnson (New Brunswick, N.J., USA) has acquired the remaining stake in Verb Surgical Inc. (Santa Clara, CA, USA), following a successful strategic collaboration with Verily, an Alphabet company. Verb Surgical's robotics and data science capabilities, combined with Johnson & Johnson's health care leadership and global reach, aim to make medical interventions smarter, less invasive and more personalized.
Read More
22 Jan 2020
Global Point of Care Testing (POCT) Market to Reach USD 46.7 Billion by 2024
 The global point of care testing (POCT) market is expected to surpass USD 37 billion by 2025, driven mainly by the migration of POCT from the hospital environment to a range of medical environments, including the workplace, home, disaster care and most recently, convenience clinics. POCT now appears to be headed for a bigger role in diagnosis and monitoring patient care. Additionally, growing awareness about early disease diagnosis and prevention has stimulated the demand for POCT for detecting cancer and infectious disease in the early stages. Moreover, the rising incidence of infectious diseases and chronic conditions, such as cardiovascular diseases and diabetes in the developing countries such as India and China, is stimulating the demand for POCT services.
Read More
16 Jan 2020
Radiomic Algorithm Predicts if Patient’s Cancer Can Return 10 Years After Treatment
 A new study by researchers at Penn Medicine (Philadelphia, PA, USA) has found that Magnetic Resonance Imaging (MRI) and an emerging field of medicine called radiomics — which uses algorithms to extract a large amount of features from medical images — could help to characterize the heterogeneity of cancer cells within a tumor and allow for a better understanding of the causes and progression of a person’s individual disease.
Read More
Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions